Aptamers generated from cell-SELEX for molecular medicine: A chemical biology approach

Accounts of Chemical Research

Volumn 43, Issue 1, 2010, Pages 48-57

  Fang, Xiaohong ^a   Tan, Weihong ^b,c  

^a INSTITUTE OF CHEMISTRY   (China)

^b UNIVERSITY OF FLORIDA   (United States)

^c HUNAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER;

ARTICLE; CHEMISTRY; COMBINATORIAL CHEMISTRY; CONFORMATION; GENETICS; HUMAN; METHODOLOGY; SYNTHESIS; TUMOR CELL LINE;

APTAMERS, NUCLEOTIDE; CELL LINE, TUMOR; HUMANS; NUCLEIC ACID CONFORMATION; SELEX APTAMER TECHNIQUE;

EID: 75449119505     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar900101s     Document Type: Article

References (52)

1. Tuerk,C.;Gold,L.SystematicEvolutionofLigandsbyExponentialEnrichment: RNALigands-BacteriophageT4DNAPolymerase.Science1990,249,505-510. (Pubitemid20248891)
2. Ellington, A. D.; Szostak, J. W. In Vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346, 818-822.
3. Osborne,S.E.;Matsumura,I.;Ellington,A.D. AptamersasTherapeuticandDiagnosticReagents:ProblemsandProspects.Curr.Opin.Chem. Biol.1997,1,5-9.(Pubitemid127435139)
4. Famulok, M.; Hartig, J. S.; Mayer, G. Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy. Chem. Rev. 2007, 107, 3715-3743.
5. Naváni, N. K.; Li, Y. Nucleic Acid Aptamers and Enzymes as Sensors. Curr. Opin. Chem. Biol. 2006, 10, 272-281. (Pubitemid 43815779)
6. Bunka, D. H.; Stockley, P. G. Aptamers come of age-at last. Nat Rev. Microbml. 2006, 4, 588-596.
7. Jiang, Y.; Zhu, C.; Ling, L.; Wan, L.; Fang, X.; Bai, C. Specific Apramer-Protein Interaction Studied by Atomic Force Microscopy. Anal. Chem. 2003, 75, 2112-2116. (Pubitemid 36542352)
8. lreson, C. R.; Kelland, L R. Discovery and development of anticancer aptamers. Mol. Cancer Ther. 2006, 5, 2957-2962.
9. Lupoid, S. E.; Hicke, B. J.; Lin, Y.; Coffey, D. S. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 2002, 62, 4029-4033.
10. Daniels, D. A.; Chen, H.; Hicke, B. J.; Swiderek, K. M.; Gold, L. ATenascin-C Aptamer Identified by Tumor Cell SELEX: Systematic Evolution of Ligands by Exponential Enrichment. Proc. Natl. Acad. Sci. USA 2003, 100, 15416-15421. (Pubitemid 38021004)
11. Cerchia, L.; Ducongé, F.; Pestourie, C.; Boulay, J.; Aissouni, Y.; Gombert, K.; Tavitian, B.; Francisas, V.; Libri, D. Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol. 2005, 3, e123.
12. Shamah, S. M.; Healy, J. M.; Cload, S. T. Complex target SELEX. Acc. Chem. Res. 2008, 41, 130-138.
13. Blank, M.; Weinschenk, T.; Priemer, M.; Schluesener, H. Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels. Selective Targeting of Endothelial Regulatory Protein Pigpen. J. Biol. Chem. 2001, 276, 16464-16468. (Pubitemid 37391695)
14. Berezovski, M. V.; Lechmann, M.; Musheev, M. U.; MaK T. W.; Krylov, S. N. Aptamer-facilitated biomarker discovery (ApIaBiD). J. Am. Chem. Soc. 2008, 130, 9137-9143.
15. Guo, K. T.; Schafer, R.; Paul, A.; Gerber, A.; Ziemer, G.; Wendel, H. P. A new technique tor the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells 2006, 24, 2220-2231.
16. Raddatz, M. S.; Dolf, A.; Endl, E.; Knolle, P.; Famulok, M.; Mayer, G. Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. Angew. Chem., Int. Ed. 2008, 47, 5190-5193.
17. Shangguan, D.; Li, Y.; Tang, Z.; Cao, Z.; Chen, H.; Mallikaratchy, P.; Sefah, K.; Yang, C.; Tan, W. Aptamers Evolved from Live Cells as Effective Molecular Probes for Cancer Study. Proc. Natl. Acad. Sci. USA. 2006, 103, 11838-11843. (Pubitemid 44215773)
18. Shangguan, D.; Meng, L.; Cao, Z.; Xiao, Z.; Fang, X.; Li, Y.; Cardona, D.; Witek, R.; Liu, C.; Tan, W. Identification of Liver Cancer-Specific Aptamers Using Whole Live Cells. Anal. Chem. 2008, 80, 721-728. (Pubitemid 351206860)
19. Sefah, K.; Tang, Z.; Shangguan, D.; Chen, H.; Lopez-Colon, D.; Li, Y.; Parekh, P.; Martin, J.; Meng, L.; Phillips, J. A.; Kim, Y. M.; Tan, W. Molecular recognition of acute myeloid leukemia using aptamers. Leukemia 2009, 23, 235-244.
20. Chen, H.; Medley, C.; Sefah, K.; Shangguan, D.; Tang, Z.; Meng, L.; Smith, J.; Tan, W. Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem. 2008, 3, 991-1001.
21. Tang, Z.; Shangguan, D.; Wang, K.; Shi, H.; Sefah, K.; Mallikratchy, P.; Chen, H.; Li, Y.; Tan, W. Selection of Aptamers for Molecular Recognition and Characterization of Cancer Cells. Anal. Chem. 2007, 79, 4900-4907. (Pubitemid 47051443)
22. Hasegawa, H.; Taira, K. I.; Sode, K.; Ikebukuro, K. Improvement of aptamer affinity by dimerization. Sensors 2008, 8, 1090-1098.
23. Müller, J.; Wulffen, B.; Putsch, B.; Mayer, G. Mutridomain targeting generates a high-affinity thrombin-lnhibiting bivalent aptamer. ChemBioChem. 2007, 8, 2223-2226.
24. Kim, Y.; Cao, Z.; Tan, W. Molecular Assembly for High-Performance Bivalent Nucleic Acid Inhibitor. Proc. Natl. Acad. Sci. USA 2008, 105, 5664-5669. (Pubitemid 351758428)
25. Negm, R. S.; Verma, M.; Srivastava, S. The Promise of Biomarkers in Cancer Screening and Detection. Trends Mol. Med. 2002, 8, 288-293. (Pubitemid 34568384)
26. Aina, O. H.; Liu, R.; Surclitfe, J. L.; Marik, J.; Pan, C. X.; Lam, K. S. From Combinatorial Chemistry to Cancer-Targeting Peptides. Mol Pharm. 2007, 4, 631-651
27. Shangguan, D.; Cao, Z.; Li, Y.; Tan, W. Aptamers Evolved from Cultured Cancer Cells Reveal Molecular Differences of Cancer Cells in Patient Samples. Clin Chem. 2007, 53, 1153-1155. (Pubitemid 46867534)
28. Huang, Y.; Chang, H.; Tan, W. Cancer Cell Targeting Using Multiple Aptamers Conjugated on Nanorods. Anal. Chem. 2008, 80, 567-572. (Pubitemid 351206842)
29. Medley, C.; Smith, J.; Tang, Z.; Wu, Y.; Bamrungsap, S.; Tan, W. Gold NanoparticleBased Colorimefric Assay for the Direct Detection of Cancerous Cells. Anal. Chem. 2008, 80, 1067-1072. (Pubitemid 351272339)
30. Herr, J.; Smith, J.; Medley, C.; Shangguan, D.; Tan, W. Aptamer-Conjugated Nanoparticles for Selective Collection and Detection of Cancer Cells. Anal. Chem. 2006, 78, 2918-2924. (Pubitemid 43726108)
31. Smith, J.; Medley, C.; Tang, Z.; Shangguan, D.; Lofton, C.; Tan, W. AptamerConjugated Nanoparticles tor the Collection and Detection of Multiple Cancer Cells. Anal. Chem. 2007, 79, 3075-3082. (Pubitemid 46640529)
32. Phillips, J.; Xu, Y.; Xia, Z.; Fan, Z.; Tan, W. Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. Anal. Chem. 2009, 81, 1033-1039.
33. linuma, H.; Okinaga, K.; Adachi, M.; Suda, K.; Sekine, T.; Sakagawa, K.; Baba, Y.; Tamura, J.; Kumagai, H.; Ida, A. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer. Int J. Cancer 2000, 89, 337-344.
34. Nagratti, S.; Sequist, L. V.; Maheswaran, S.; Bell, D. W.; Irimial, D.; Ulkus, L.; Smith, M. R.; Kwak, E. L.; Digumarthy, S.; Muzikansky, A.; Ryan, P.; Balis, U. J.; Tompkins, R. G.; Haber, D. A.; Toner, M. Isolation of rare circulating tumor cells in cancer patients by microchip technology. Nature 2007, 450, 1235-1239.
35. Morishita, R.; Gibbons, G. H.; Horiuchi, M.; Ellison, K. E.; Nakama, M.; Zhang, L.; Kaneda, Y.; Ogihara, T.; Dzau, V. J. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. USA. 1995, 92, 5855-5859.
36. Chaloin, L.; Lehmann, M. J.; Sczakiel, G.; Restie, T. Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1. Nucleic Acids Res. 2002, 30, 4001-4008.
37. Farokhzad, O. C.; Jon, S.; Khademhosseini, A.; Tran, T. N.; Lavan, D. A.; Langer, R. Nanoparticle-aptamer bioconjugates: A new approach tor targeting prostate cancer cells. Cancer Res. 2004, 64, 7668-7672.
38. Gu, F.; Zhang, L.; Teply, B. A.; Mann, N.; Wang, A.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Precise engineering of targeted nanoparticles by using selfassembled biointegrated block copolymers. Proc. Natl. Acad. Sci. U.S.A 2008, 105, 2586-2591.
39. Chu, T. C.; Twu, K. Y.; Ellington, A. D.; Levy, M. Aptamer mediated siRNA delivery. Nucleic Acids Res. 2006, 34, e73.
40. Xiao, Z.; Shangguan, D.; Cao, Z.; Fang, X.; Tan, W. Cell-specific internalization study of an aptamer from whole cell selection. Chemistry, A European Journal 2008, 14, 1769-1775.
41. Chu, T. C.; Marks, J. W., Ill; Lavery, L. A.; Faulkner, S.; Rosenblum, M. G.; Ellington, A. D.; Levy, M. Aptamer: Toxin conjugates that specifically target prostate tumor cells. Cancer Res. 2006, 66, 5989-5992.
42. Farokhzad, O. C.; Cheng, J.; Teply, B. A.; Sherifi, I.; Jon, S.; Kantoff, P. W.; Richie, J. P.; Langer, R. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. USA 2006, 103, 6315-6320.
43. Huang, Y.; Shangguan, D.; Liu, H.; Phillips, J. A.; Zhang, X.; Chen, Y.; Tan, W. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. ChemBioChem. 2009, 10, 862-868.
44. Dolmans, D. E.; Fukumura, D.; Jain, R. K. Photodynamic therapy for cancer. Nat Rev. Cancer2003, 3, 380-387.
45. Oseroff, A. R.; Ohuoha, D.; Hasan, T.; Bommer, J. C.; Yarmush, M. L Antibodytargeted photolysis: Selective photodesfruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. Proc. Natl. Acad. Sci. U.S.A 1986, 83, 8744-8748.
46. Mallikaratchy, P.; Tang, Z.; Tan, W. Cell specific aptamer- photosensitizer conjugates as a molecular tool in photodynamic therapy. ChemMedChem. 2008, 3, 425-428.
47. Huang, Y.; Sefah, K.; Bamrungsap, S.; Chang, H.; Tan, W. Selective photothermal therapy tor mixed cancer cells using aptamer-conjugated nanorods. Langmuir 2008, 24, 11860-11865.
48. Wu, C. C.; Yates, J. R., III. The Application of Mass Spectrometry to Membrane Proteomics. Nat. Biotechnol. 2003, 21, 262-267. (Pubitemid 36314809)
49. Shangguan, D.; Cao, Z.; Meng, L.; Mallikaratchy, P.; Sefah, K.; Wang, H.; Li, Y.; Tan, W. Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J. ProteomeRes. 2008, 7, 2133-2139.
50. Müller-Tidow, C.; Schwäble, J.; Steffen, B.; Tidow, N.; Brandt, B.; Becker, K.; Schulze-Bahr, E.; Halfter, H.; Vogt, U.; Metzger, R.; Schneider, P. M.; Büchner, T.; Brandts, C.; Berdel, W. E.; Serve, H. High-Throughput Analysis of Genome-Wide Receptor Tyrosine Kinase Expression in Human Cancers Identifies Potential Novel Drug Targets. Clin. Cancer Res. 2004, 10, 1241-1249. (Pubitemid 38365213)
51. Mallikaratchy, P.; Tang, Z.; Kwame, S.; Meng, L.; Shangguan, D.; Tan, W. Aptamer directly evolved from five cells recognizes membrane bound lmmunoglobin heavy mu chain in burkitt's lymphoma cells. Mol. Cell Proteomics 2007, 6, 2230-2238.
52. Thomas, M. D.; Srivastava, B.; Allman, D. Regulation of peripheral B-cell maturation. Cell. Immun. 2006, 239, 92-102.